back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-14 15:02 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,881
+29,762 vol $0.50 each |
29,762 | |
| Filed 2025-11-14 15:01 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 15:00 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$25,000
+59,524 vol $0.42 each |
59,524 | |
| Filed 2025-11-14 14:57 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:56 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$44,662
+89,325 vol $0.50 each |
89,325 | |
| Filed 2025-11-14 14:55 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:53 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$75,033
+178,650 vol $0.42 each |
428,650 | |
| Filed 2025-11-14 14:46 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$595,240
+1,190,480 vol $0.50 each |
1,190,480 | |
| Filed 2025-11-14 14:45 Tx date 2022-04-06 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:43 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,000,003
+2,380,960 vol $0.42 each |
4,880,960 | |
| Filed 2025-11-13 19:31 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,875
+29,750 vol $0.50 each |
29,750 | |
| Filed 2025-11-13 19:30 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:28 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$24,990
+59,500 vol $0.42 each |
559,500 | |
| Filed 2025-11-13 19:27 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$17,877
+35,755 vol $0.50 each |
35,755 | |
| Filed 2025-11-13 19:26 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:25 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$30,034
+71,510 vol $0.42 each |
71,510 | |
| Filed 2025-11-13 19:24 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:22 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$59,525
+119,050 vol $0.50 each |
119,050 | |
| Filed 2025-11-13 19:21 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:20 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,002
+238,100 vol $0.42 each |
238,100 |